We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-17.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$47.7B
AUM Growth
-$12.1B
Cap. Flow
+$1.21B
Cap. Flow %
2.54%
Top 10 Hldgs %
20.23%
Holding
2,980
New
31
Increased
2,361
Reduced
322
Closed
49

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$22.7M
2
CNC icon
Centene
CNC
+$20M
3
IR icon
Ingersoll Rand
IR
+$18.4M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$16.8M
5
DLR icon
Digital Realty Trust
DLR
+$15.4M

Sector Composition

Rank Sector Weight
1 Technology 21.47%
2 Healthcare 14.79%
3 Financials 13.95%
4 Consumer Discretionary 9.78%
5 Communication Services 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEF.B icon
2301
Greif Class B
GEF.B
$4.17B
$368K ﹤0.01%
9,176
MITK icon
2302
Mitek Systems
MITK
$830M
$368K ﹤0.01%
46,709
+460
+1% +$3.91K
ACRE
2303
Ares Commercial Real Estate
ACRE
$264M
$367K ﹤0.01%
52,460
+10,408
+25% +$147K
SHBI icon
2304
Shore Bancshares
SHBI
$798M
$366K ﹤0.01%
33,727
+13,890
+70% +$203K
TSC
2305
DELISTED
TriState Capital Holdings, Inc.
TSC
$366K ﹤0.01%
37,803
+325
+0.9% +$6.51K
SNR
2306
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$366K ﹤0.01%
142,897
+9,947
+7% +$63.5K
NRIM icon
2307
Northrim BanCorp
NRIM
$588M
$365K ﹤0.01%
54,120
+12,400
+30% +$107K
NOVA
2308
DELISTED
Sunnova Energy
NOVA
$364K ﹤0.01%
36,144
+25,013
+225% +$343K
CDMO
2309
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$364K ﹤0.01%
71,284
+283
+0.4% +$1.71K
VRTV
2310
DELISTED
VERITIV CORPORATION
VRTV
$364K ﹤0.01%
46,302
+2,435
+6% +$30.9K
BDSI
2311
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$364K ﹤0.01%
96,074
+151
+0.2% +$742
VIR icon
2312
Vir Biotechnology
VIR
$1.5B
$362K ﹤0.01%
+10,554
New +$284K
VPG icon
2313
Vishay Precision Group
VPG
$922M
$362K ﹤0.01%
18,015
+25
+0.1% +$734
ERII icon
2314
Energy Recovery
ERII
$428M
$361K ﹤0.01%
48,586
+200
+0.4% +$1.9K
RIGL icon
2315
Rigel Pharmaceuticals
RIGL
$752M
$360K ﹤0.01%
23,095
-200
-0.9% -$4.26K
DVAX
2316
DELISTED
Dynavax Technologies
DVAX
$359K ﹤0.01%
101,799
-27
-0% -$125
MGNI icon
2317
Magnite
MGNI
$3.55B
$359K ﹤0.01%
64,758
+7,147
+12% +$65.7K
BELFB
2318
Bel Fuse Inc Class B
BELFB
$4.26B
$358K ﹤0.01%
36,715
-210
-0.6% -$3.06K
LQDT icon
2319
Liquidity Services
LQDT
$1.31B
$357K ﹤0.01%
92,067
+100
+0.1% +$476
CNR
2320
Core Natural Resources Inc
CNR
$4.52B
$357K ﹤0.01%
96,874
+5,747
+6% +$45.5K
CNCE
2321
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$357K ﹤0.01%
40,349
+6,155
+18% +$60.7K
GERN icon
2322
Geron
GERN
$969M
$356K ﹤0.01%
299,244
+20,505
+7% +$25.1K
ODC icon
2323
Oil-Dri
ODC
$1.33B
$356K ﹤0.01%
21,278
+4,000
+23% +$68.6K
HUD
2324
DELISTED
Hudson Ltd. Class A Common Shares
HUD
$354K ﹤0.01%
70,593
+6,900
+11% +$68.4K
TLRA
2325
DELISTED
Telaria, Inc.
TLRA
$354K ﹤0.01%
58,927
+2,500
+4% +$24.8K

Similar funds

RhumbLine Advisers's Q1 2020 Portfolio in Review

As of Q1 2020, RhumbLine Advisers held 2,980 positions worth $47.7B, down 20% from $59.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 2.7%. RhumbLine Advisers opened 31 new positions and exited 49, leaving the 2,980-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2020 buy was PPD, Inc. Common Stock: 58,466 shares worth $1.04M.
  • RhumbLine Advisers added most to Prologis in Q1 2020, an estimated $22.7M increase.
  • RhumbLine Advisers's biggest Q1 2020 reduction was Apple, cutting an estimated $70.6M.
  • RhumbLine Advisers fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $34.9M.
  • RhumbLine Advisers's ten largest holdings make up 20% of its $47.7B portfolio in Q1 2020.
  • RhumbLine Advisers opened 31 new positions and closed 49 in Q1 2020.
  • RhumbLine Advisers's portfolio value fell 20% quarter-over-quarter to $47.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2020, filed 6 May 2020.